Brain Imaging and Neuroimaging Market to Grow with a CAGR of 5.62% through 2028
Expanding
applications in drug development are expected to drive the Global Brain Imaging
and Neuroimaging Market growth in the forecast period, 2024-2028.
According
to TechSci Research report, “Brain Imaging and Neuroimaging Market – Global
Industry Size, Share, Trends, Competition Forecast & Opportunities,
2028”, the Global Brain Imaging and Neuroimaging Market stood at USD 11.12
billion in 2022 and is anticipated to grow with a CAGR of 5.62% in the forecast
period, 2024-2028. One of the primary drivers propelling the growth of the
global brain imaging and neuroimaging market is the continuous evolution and
enhancement of imaging technologies. The field has witnessed remarkable
progress in modalities such as Magnetic Resonance Imaging (MRI), Computed
Tomography (CT), Positron Emission Tomography (PET), Single-Photon Emission
Computed Tomography (SPECT), and functional MRI (fMRI). These advancements are
not only improving the resolution and accuracy of imaging but also expanding
the range of applications. High-resolution imaging, real-time functional
connectivity mapping, and the integration of artificial intelligence for image
analysis are some of the notable technological innovations that are driving the
market forward.
The increasing
prevalence of neurological disorders and conditions is a significant market
driver. Conditions such as Alzheimer's disease, Parkinson's disease, multiple
sclerosis, and various psychiatric disorders are on the rise globally,
particularly with an aging population. As these disorders become more
prevalent, there is a growing need for advanced diagnostic tools to enable
early detection and effective treatment. Brain imaging and neuroimaging
techniques play a pivotal role in providing insights into the structural and
functional changes in the brain associated with these disorders. This increased
demand for diagnostic capabilities is fueling the expansion of the market.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on
"Global Brain Imaging and Neuroimaging Market.”
The Global Brain
Imaging and Neuroimaging Market is segmented into Imaging Type, End User, Regional Distribution, And Company.
Based
on the Imaging Type, Functional Magnetic Resonance Imaging (fMRI) emerged as
the dominant segment in the global market for Global Hematology Brain Imaging and Neuroimaging in 2022. fMRI
is non-ionizing, meaning it does not expose individuals to ionizing radiation.
In contrast, imaging modalities like Computed Tomography (CT) and Positron
Emission Tomography (PET) involve ionizing radiation, which can pose potential
health risks with repeated exposure. The non-invasive nature of fMRI makes it a
safer option for longitudinal studies and repeated imaging sessions. Moreover,
fMRI is well-suited for studying cognitive processes and has become a
cornerstone in functional neuroimaging research. Its versatility in
investigating a wide range of cognitive functions, from perception and memory
to decision-making, contributes to its widespread adoption in both academic and
clinical settings.
Based
on the End User, Hospitals and clinics emerged as the dominant segment in the
global market for Global Brain Imaging and Neuroimaging Market in 2022. hospitals serve as comprehensive
healthcare facilities, offering a wide range of medical services, including
diagnostic imaging. The complex nature of neurological disorders often requires
a multidisciplinary approach to diagnosis and treatment, making hospitals the
primary hub for the integration of neuroimaging into patient care. From initial
diagnosis to treatment planning and monitoring, hospitals house the expertise
and infrastructure needed for the full spectrum of neurological care. the
advanced imaging technologies employed in the diagnosis of neurological
conditions, such as Magnetic Resonance Imaging (MRI), Computed Tomography (CT),
and Positron Emission Tomography (PET), are typically available in hospital
settings. These modalities provide detailed insights into brain structures and
functions, aiding in the accurate diagnosis and monitoring of various
neurological disorders. The sophisticated nature of these technologies often
necessitates the resources and expertise found in hospital environments.
North
America emerged as the dominant player in the
Global Brain Imaging and Neuroimaging Market in 2022, holding the largest market share.
North America has a robust and advanced healthcare infrastructure, particularly
in the United States and Canada. These countries are at the forefront of
adopting and integrating innovative medical technologies, including
state-of-the-art brain imaging and neuroimaging equipment. The availability of
cutting-edge imaging modalities in major healthcare facilities across North
America positions the region as a leader in the global market. significant
investments in research and development within the healthcare sector contribute
to the dominance of North America in the neuroimaging market. The region is
home to numerous research institutions, academic centers, and pharmaceutical
companies that actively engage in neuroscience research and clinical trials.
This emphasis on research fosters the development and adoption of advanced
brain imaging technologies, further solidifying North America's position in the
market. a high prevalence
of neurological disorders in North America drives the demand for brain imaging
and neuroimaging technologies. Conditions such as Alzheimer's disease,
Parkinson's disease, and various psychiatric disorders are on the rise,
creating a substantial market for diagnostic tools that can provide accurate
and early assessments. The proactive approach to addressing neurological health
issues in North America underscores the significance of neuroimaging in the
region.
Major companies
operating in Global Brain Imaging and Neuroimaging Market are:
- Varian Medical
System
- General Electric
Company
- Siemens AG
- Philips Healthcare
- Toshiba Medical
Systems
- Hitachi Medical
Systems
- Esaote SpA
- Sanrad Medical
Systems Pvt. Ltd
Download Free Sample Report
Customers can
also request for 10% free customization on this report.
“The
Global Brain Imaging and Neuroimaging Market is poised for robust growth in the
coming years. Anticipated technological advancements, particularly in imaging
resolution and data analysis capabilities, are expected to enhance diagnostic
precision and expand the applications of neuroimaging technologies. The rising
prevalence of neurological disorders worldwide, coupled with an increasing
emphasis on early diagnosis and intervention, will fuel the demand for advanced
imaging solutions. Integration of artificial intelligence in neuroimaging
processes is anticipated to revolutionize data interpretation, improving
efficiency and accuracy. Additionally, the expanding applications of neuroimaging
in drug development and personalized medicine will contribute to market growth..”
said Mr. Karan Chechi, Research Director with TechSci Research, a
research-based management consulting firm.
“Brain
Imaging and Neuroimaging Market - Global Industry Size, Share, Trends,
Opportunity, and Forecast, 2018-2028 Segmented By Imaging Type (Functional
Magnetic Resonance Imaging (fMRI), Computed Tomography (CT), Positron Emission
Tomography (PET), Electroencephalography (EEG), Magnetoencephalography (MEG),
Near Infrared Spectroscopy (NIRS)), By End User (Hospitals & Clinics,
Ambulatory Surgical Centers, Others) Region and Competition”,
has evaluated the future growth potential of Global Brain Imaging and Neuroimaging
Market and provides statistics & information on market size, structure and
future market growth. The report intends to provide cutting-edge market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in Global Brain Imaging and
Neuroimaging Market.
Contact
Mr. Ken
Mathews
TechSci Research LLC
420
Lexington Avenue, Suite 300,
New York,
United States- 10170
Tel:
+13322586602
Email: [email protected]
Website: www.techsciresearch.com